TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis

APMIS

Volumn 117, Issue 8, 2009, Pages 575-582

  Rostad, Kari ^a   Hellwinkel, Olaf J C ^b   Haukaas, Svein A ^a,c   Halvorsen, Ole J ^c   Øyan, Anne M ^a,c   Haese, Alexander ^b   BudÄus, Lars ^b   Albrecht, Heiko ^b   Akslen, Lars A ^a,c   Schlomm, Thorsten ^b   Kalland, Karl Henning ^a,c,d  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d Centre for Research in Virology   (Norway)

Author keywords

ERG, gene fusion; Prostate cancer; TMPRSS2; Urine screening

Indexed keywords

COMPLEMENTARY DNA; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR ERG;

ADULT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FUSION GENE; GENE FUSION; GENETIC VARIABILITY; GLEASON SCORE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MASSAGE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE MASSAGE; REAL TIME POLYMERASE CHAIN REACTION; TMPRSS2 ERG GENE; URINALYSIS;

AGED; BASE SEQUENCE; CELL LINE, TUMOR; EXONS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 68349107056     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02517.x     Document Type: Article

References (25)

1. Petrovics G, Liu A, Shaheduzzaman S, Furasato B, Sun C, Chen Y, et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene 2005 24 : 3847 52.
2. Rostad K, Mannelqvist M, Halvorsen OJ, Oyan AM, Bo TH, Stordrange L, et al. ERG upregulation and related ETS transcription factors in prostate cancer. Int J Oncol 2007 30 : 19 32.
3. Lin B, Ferguson C, White JT, Wang S, Vessella R, True LD, et al. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res 1999 59 : 4180 4.
4. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005 310 : 644 8.
5. Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, et al. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res 2008 68 : 73 80.
6. Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, Helgeson BE, et al. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res 2006 66 : 3396 400.
7. Clark J, Merson S, Jhavar S, Flohr P, Edwards S, Foster CS, et al. Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene 2007 26 : 2667 73.
8. Soller MJ, Isaksson M, Elfving P, Soller W, Lundgren R, Panagopoulos I. Confirmation of the high frequency of the TMPRSS2/;ERG fusion gene in prostate cancer. Genes Chromosomes Cancer 2006 45 : 717 9.
9. Winnes M, Lissbrant E, Damber JE, Stenman G. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer. Oncol Rep 2007 17 : 1033 6.
10. Yoshimoto M, Joshua AM, Chilton-Macneill S, Bayani J, Selvarajah S, Evans AJ, et al. Three-color FISH analysis of TMPRSS2/;ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. Neoplasia 2006 8 : 465 9.
11. Perner S, Demichelis F, Beroukhim R, Schmidt FH, Mosquera JM, Setlur S, et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 2006 66 : 8337 41.
12. Wang J, Cai Y, Ren C, Ittmann M. Expression of variant TMPRSS2/;ERG fusion messenger RNAs is associated with aggressive prostate cancer. Cancer Res 2006 66 : 8347 51.
13. Laxman B, Tomlins SA, Mehra R, Morris DS, Wang L, Helgeson BE, et al. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Neoplasia 2006 8 : 885 8.
14. Hessels D, Smit FP, Verhaegh GW, Witjes JA, Cornel EB, Schalken JA. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clin Cancer Res 2007 13 : 5103 8.
15. Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, Dobler G, et al. hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis. Cancer Res 2006 66 : 3531 40.
16. Lee HL, Pienta KJ, Kim WJ, Cooper CR. The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro. Int J Oncol 2003 22 : 921 6.
17. Petersen K, Oyan AM, Rostad K, Olsen S, Bo TH, Salvesen HB, et al. Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization. Anal Biochem 2007 366 : 46 58.
18. Lee YG, Korenchuk S, Lehr J, Whitney S, Vessela R, Pienta KJ. Establishment and characterization of a new human prostatic cancer cell line: DuCaP. In Vivo 2001 15 : 157 62.
19. Nam RK, Sugar L, Yang W, Srivastava S, Klotz LH, Yang LY, et al. Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer. Br J Cancer 2007 97 : 1690 5.
20. Barry MPS, Demichelis F, Rubin MA. TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. Urology 2007 70 : 630 3.
21. Tomlins SA, Laxman B, Varambally S, Cao X, Yu J, Helgeson BE, et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 2008 10 : 177 88.
22. Rajput AB, Miller MA, De Luca A, Boyd N, Leung S, Hurtado-Coll A, et al. Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers. J Clin Pathol 2007 60 : 1238 43.
23. Demichelis F, Fall K, Perner S, Andren O, Schmidt F, Setlur SR, et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 2007 26 : 4596 9.
24. Saramaki OR, Harjula AE, Martikainen PM, Vessella RL, Tammela TL, Visakorpi T. TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis. Clin Cancer Res 2008 14 : 3395 400.
25. Mehra R, Tomlins SA, Yu J, Cao X, Wang L, Menon A, et al. Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer. Cancer Res 2008 68 : 3584 90.